Treatment of Hyperkeratosis with Yeast Involvement

Introduction to Treatment

The American College of Dermatology recommends combining topical keratolytics, such as urea 10-40% or salicylic acid 5-10%, with topical antifungal therapy targeting the specific yeast organism, while addressing the hyperkeratosis through mechanical debridement when appropriate, for the treatment of hyperkeratosis with yeast involvement 1

Mechanical debridement should be performed as first-line therapy for non-fragile hyperkeratotic lesions, with professional blade or scalpel debridement by a podiatrist being most effective, and after debridement, apply emollients and non-adherent dressings to protect the skin 2
The American Podiatric Medical Association suggests that topical keratolytics, such as urea 10-40% cream, are essential and FDA-approved for hyperkeratosis management, gently dissolving the intracellular matrix and loosening the horny layer, promoting shedding of scaly skin 1
The use of salicylic acid 5-10% is FDA-approved as a topical aid for removal of excessive keratin in hyperkeratotic disorders, particularly useful for plantar and dorsal hyperkeratotic lesions 1

The American Diabetes Association advises against using aggressive blade debridement if epidermolytic hyperkeratosis is suspected, as this can cause severe complications 2
The American Podiatric Medical Association recommends avoiding the use of chemical plasters for corn removal, especially in diabetic patients 3
Regular reassessment after 2 weeks of treatment, including both clinical assessment and mycological testing, is necessary to confirm yeast eradication, as suggested by the Infectious Diseases Society of America 1
The American College of Dermatology suggests that pressure redistribution and cushioning, footwear modifications, and moisture control between digits are important adjunctive measures to prevent recurrence of hyperkeratosis 2
The National Institute of Health recommends the use of topical corticosteroids, such as high-potency corticosteroids twice daily, if significant inflammation is present 6